カイオム・バイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/03/24 | 1,000 | 1,021 | 999 | 1,020 | +5 | +0.5% | 202,700 |
2015/03/23 | 1,035 | 1,053 | 1,015 | 1,015 | -13 | -1.3% | 238,900 |
2015/03/20 | 999 | 1,044 | 996 | 1,028 | +18 | +1.8% | 408,900 |
2015/03/19 | 1,053 | 1,067 | 987 | 1,010 | -55 | -5.2% | 767,800 |
2015/03/18 | 1,030 | 1,071 | 1,025 | 1,065 | +3 | +0.3% | 576,400 |
2015/03/17 | 1,164 | 1,170 | 1,049 | 1,062 | -100 | -8.6% | 1,067,000 |
2015/03/16 | 1,215 | 1,219 | 1,160 | 1,162 | -80 | -6.4% | 631,000 |
2015/03/13 | 1,245 | 1,260 | 1,240 | 1,242 | -6 | -0.5% | 126,200 |
2015/03/12 | 1,256 | 1,265 | 1,245 | 1,248 | -18 | -1.4% | 114,900 |
2015/03/11 | 1,230 | 1,289 | 1,225 | 1,266 | +28 | +2.3% | 169,400 |
2015/03/10 | 1,249 | 1,259 | 1,233 | 1,238 | -9 | -0.7% | 114,300 |
2015/03/09 | 1,266 | 1,266 | 1,246 | 1,247 | -20 | -1.6% | 104,500 |
2015/03/06 | 1,256 | 1,275 | 1,253 | 1,267 | +12 | +1% | 108,000 |
2015/03/05 | 1,258 | 1,277 | 1,251 | 1,255 | -6 | -0.5% | 165,600 |
2015/03/04 | 1,244 | 1,275 | 1,240 | 1,261 | +6 | +0.5% | 189,300 |
2015/03/03 | 1,290 | 1,295 | 1,245 | 1,255 | -36 | -2.8% | 335,500 |
2015/03/02 | 1,301 | 1,306 | 1,289 | 1,291 | -13 | -1% | 146,100 |
2015/02/27 | 1,300 | 1,308 | 1,295 | 1,304 | +4 | +0.3% | 120,000 |
2015/02/26 | 1,313 | 1,316 | 1,300 | 1,300 | -15 | -1.1% | 98,400 |
2015/02/25 | 1,309 | 1,320 | 1,298 | 1,315 | +1 | +0.1% | 178,300 |
2015/02/24 | 1,334 | 1,335 | 1,309 | 1,314 | -6 | -0.5% | 140,000 |
2015/02/23 | 1,318 | 1,337 | 1,310 | 1,320 | +2 | +0.2% | 127,300 |
2015/02/20 | 1,332 | 1,348 | 1,301 | 1,318 | -26 | -1.9% | 181,100 |
2015/02/19 | 1,345 | 1,364 | 1,329 | 1,344 | +8 | +0.6% | 185,100 |
2015/02/18 | 1,312 | 1,338 | 1,311 | 1,336 | +23 | +1.8% | 154,000 |
2015/02/17 | 1,300 | 1,315 | 1,287 | 1,313 | +27 | +2.1% | 141,000 |
2015/02/16 | 1,298 | 1,308 | 1,282 | 1,286 | -24 | -1.8% | 187,300 |
2015/02/13 | 1,311 | 1,315 | 1,300 | 1,310 | -6 | -0.5% | 114,200 |
2015/02/12 | 1,315 | 1,324 | 1,312 | 1,316 | +1 | +0.1% | 83,100 |
2015/02/10 | 1,314 | 1,337 | 1,308 | 1,315 | -18 | -1.4% | 109,600 |
2015/02/09 | 1,317 | 1,338 | 1,310 | 1,333 | +13 | +1% | 95,600 |
2015/02/06 | 1,308 | 1,349 | 1,305 | 1,320 | -2 | -0.2% | 128,000 |
2015/02/05 | 1,293 | 1,330 | 1,286 | 1,322 | +34 | +2.6% | 268,700 |
2015/02/04 | 1,309 | 1,316 | 1,280 | 1,288 | -24 | -1.8% | 315,000 |
2015/02/03 | 1,324 | 1,332 | 1,309 | 1,312 | -12 | -0.9% | 128,100 |
2015/02/02 | 1,335 | 1,338 | 1,320 | 1,324 | -10 | -0.7% | 113,800 |
2015/01/30 | 1,347 | 1,350 | 1,328 | 1,334 | -6 | -0.4% | 137,500 |
2015/01/29 | 1,361 | 1,364 | 1,337 | 1,340 | -26 | -1.9% | 166,700 |
2015/01/28 | 1,345 | 1,368 | 1,343 | 1,366 | +21 | +1.6% | 130,100 |
2015/01/27 | 1,353 | 1,360 | 1,341 | 1,345 | -15 | -1.1% | 111,400 |
2015/01/26 | 1,328 | 1,362 | 1,328 | 1,360 | +12 | +0.9% | 146,700 |
2015/01/23 | 1,350 | 1,358 | 1,344 | 1,348 | -12 | -0.9% | 127,900 |
2015/01/22 | 1,375 | 1,383 | 1,350 | 1,360 | -15 | -1.1% | 188,100 |
2015/01/21 | 1,380 | 1,414 | 1,373 | 1,375 | -2 | -0.1% | 237,900 |
2015/01/20 | 1,390 | 1,394 | 1,377 | 1,377 | -10 | -0.7% | 165,600 |
2015/01/19 | 1,375 | 1,390 | 1,364 | 1,387 | +8 | +0.6% | 139,700 |
2015/01/16 | 1,375 | 1,382 | 1,359 | 1,379 | -5 | -0.4% | 200,300 |
2015/01/15 | 1,384 | 1,390 | 1,373 | 1,384 | +3 | +0.2% | 152,300 |
2015/01/14 | 1,382 | 1,405 | 1,371 | 1,381 | -10 | -0.7% | 246,000 |
2015/01/13 | 1,362 | 1,407 | 1,362 | 1,391 | +11 | +0.8% | 223,500 |
2351~
2400
件表示中 / 3150件
類似銘柄と比較する
現在ご覧いただいている「カイオム」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カイオム | 9,900円 | +2.6% | - | 0.00% | - | 5.73倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
ノイルイミューン | 16,500円 | -5.1% | - | 0.00% | - | 1.43倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
日ケミファ | 150,100円 | +2.5% | - | 3.33% | 90.26倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
VIS | 91,000円 | +87.8% | +265.7% | 0.00% | 54.65倍 | 2.51倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
カルナバイオ | 30,400円 | -43.1% | - | 0.00% | - | 1.81倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム